AFWG shall not bear any responsibility for any content on such sites. Any link to a third-party site does not constitute an endorsement of the third party, their site or services. AFWG also makes no warranties as to the content of such sites.
Would you like to continue?
Currently, antifungal susceptibility testing is not universally accepted as a crucial tool in improving invasive fungal infection (IFI) management. What does the evidence suggest? Is antifungal susceptibility testing really useful for clinical management?
In this module, Dr Sarah Kidd tackles the controversial topic of antifungal susceptibility testing and explains the important role it plays in detecting unexpected resistance, contributing to local epidemiology data and, ultimately, in overall fungal disease management.
Register online to complete our free education module on antifungal susceptibility testing.